▩ ID9606/2a-c: Dispositive eines Virus
◈ Wyden-Grassley Sovaldi Investigation Finds Revenue-Driven Pricing Strategy Behind $84,000 Hepatitis Drug | The United States Senate Committee on Finance

Type: Webpage

Identifier:
4F47FSC7
Description

Wyden-Grassley Sovaldi Investigation Finds Revenue-Driven Pricing Strategy Behind $84,000 Hepatitis Drug